Breast Cancer Quad, IHC 59 Tests [meso]epigen system™ – Advanced epigenetic
Breast Cancer Quad, IHC 59 Tests [meso]epigen system™ – Advanced epigeneticBreast Cancer Quad Marker Panel, IHC Test Overview The Breast Cancer Quad Marker Panel by Immunohistochemistry (IHC) is an advanced diagnostic test used to evaluate four important biomarkers in breast cancer tissue. This panel helps oncologists classify the cancer type, assess prognosis, and guide targeted treatment decisions. Markers Included Estrogen Receptor (ER) Progesterone Receptor (PR) HER2 neu Ki 67 Proliferation Index Why This Test is
Pay in 4 interest-free payments of $481.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5